Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA double-strand breaks (DSBs) are critical lesions in the genome resulting from various endogenous and exogenous factors, including ionizing radiation like alpha particles. They involve the breakage of both DNA strands and can lead to genomic instability, cell death, or mutations if not properly repaired. DSBs are targets for cancer therapy, either directly through DNA damaging agents or indirectly through inhibition of repair pathways. However, inappropriate targeting or misrepair of DSBs can also contribute to adverse effects and therapy resistance.
Induction of DNA double-strand breaks through various mechanisms, including direct DNA damage, inhibition of repair pathways, or generation of reactive oxygen species.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Double-Strand Breaks (DSBs) (DSBs).